Add-Ons of Heart Disease from the Cardiosurgical Perspective: Gender, Blood Groups and Renal Function
Medical Sciences · 23.03.2026 · 14 (1) · 158
DOI: 10.3390/medsci14010158 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Sciences, online erschienen am 23.03.2026. Verfasst von Madeline Günther und 3 weiteren Autor:innen. Beteiligte Einrichtung: Heart Surgery, University Hospital Marburg and Giessen, 35043 Marburg, Germany. Hauptthemen laut MEDLINE: ABO Blood-Group System, Coronary Artery Disease, Heart Valve Diseases, Heart Diseases. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cardiac Promotion Society Marburg.
Abstract (Originalsprache)
Background/Objectives: This retrospective exploratory study aimed to characterize sex-specific patterns of coronary artery disease (CAD) and valvular heart disease (VHD) in a cardiac surgical cohort. In clinical routine, men appear to be more commonly affected by obstructive CAD, whereas women more frequently present valvular heart disease requiring surgical intervention. It remains unclear whether these sex-specific patterns are related to ABO blood groups and selected clinical parameters.
Methods
Here, we retrospectively analyzed 983 patients admitted between 2020 and 2024 to a single cardiac centre with CAD and/or VHD requiring valve replacement. Patients were stratified by sex and disease entity (CAD only, CAD + VHD, isolated VHD). ABO and Rhesus factor distributions, cardiovascular risk factors, body mass index (BMI), and renal function (estimated glomerular filtration rate, eGFR) were assessed. Group comparisons were performed using Chi-square and Welch’s t-tests. Associations were evaluated using multivariable logistic and linear regression models adjusted for age, BMI, diabetes mellitus, hypertension, smoking, and eGFR.
Results
Men were predominantly represented in the CAD-only group, whereas women more frequently underwent valve replacement, either isolated or combined with CAD (p < 0.001). When comparing the overall study cohort, blood group O was less prevalent in women than in men (p = 0.031), whereas blood group A was more frequent among female patients, although this difference did not reach statistical significance. Moreover, patients with valve disease demonstrated lower eGFR compared with those without valve involvement (men: −6.3 mL/min/1.73 m2, p = 0.0036; women: −10.4 mL/min/1.73 m2, p = 0.0019). This effect remained independently associated with reduced eGFR, with women slightly more affected.
Conclusions
Gender- specific diseases should be included as secondary diagnoses when considering cardiac surgery. Nephrological complications in the postoperative period can be an important factor in assessing the benefits of surgery. Blood group O was more common in male Patients, suggesting that cardiovascular diseases also exhibit blood group dependence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Heart Surgery, University Hospital Marburg and Giessen, 35043 Marburg, Germany.
- Cardiovascular Research Laboratory, Heart Center, Marburg University, 35043 Marburg, Germany.
ORCID-Profile: Ardawan J Rastan
Förderung
- Cardiac Promotion Society Marburg
Zitieren
APA
Günther, M., Zilakov, D., Rastan, A. J., & Vogt, S. (2026). Add-Ons of Heart Disease from the Cardiosurgical Perspective: Gender, Blood Groups and Renal Function. Medical Sciences, 14(1), 158. https://doi.org/10.3390/medsci14010158
Vancouver
Günther M, Zilakov D, Rastan AJ, Vogt S. Add-Ons of Heart Disease from the Cardiosurgical Perspective: Gender, Blood Groups and Renal Function. Medical Sciences. 2026;14(1):158. doi:10.3390/medsci14010158
BibTeX
@article{Gnther2026,
author = {Günther, Madeline and Zilakov, Dimitrij and Rastan, Ardawan J and Vogt, Sebastian},
title = {Add-Ons of Heart Disease from the Cardiosurgical Perspective: Gender, Blood Groups and Renal Function},
journal = {Medical Sciences},
year = {2026},
volume = {14},
number = {1},
pages = {158},
doi = {10.3390/medsci14010158}
}
EUVIMED